Discover
BCYC
Bicycle Therapeutics plc
4.21
2 x 3.09
2 x 5.37
bid
ask
-
0.03
0.71%
2 @ 04:00 PM
4.21 +0.00 (0.00%)
| Ytd | -40.54% | |
| 1y | -40.11% |
4.18
day range
4.33
3.92
52 week range
9.18
| Open | 4.23 | Prev Close | 4.24 | Low | 4.18 | High | 4.33 | Mkt Cap | 293.91M |
| Vol | 321.39K | Avg Vol | 455.24K | EPS | -3.15 | P/E | N/A | Forward P/E | -3.09 |
| Beta | 0.93 | Short Ratio | 14.44 | Inst. Own | 92.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 4.45 | 200-d Avg | 5.98 | 1yr Est | 29.55 |
| Income Statement | |||
| Total Revenue | 887.00K | ||
| Revenues (USD) | 887.00K | ||
| Gross Profit | 887.00K | ||
| Operating Expenses | 66.37M | ||
| Research and Development Expense | 48.90M | ||
| Selling, General and Administrative Expense | 17.47M | ||
| Operating Income | -65.48M | ||
| Interest Expense | 48.00K | ||
| Income Tax Expense | 172.00K | ||
| Net Income | -60.82M | ||
| Net Income Common Stock | -60.82M | ||
| Net Income Common Stock (USD) | -60.82M | ||
| Consolidated Income | -60.82M | ||
| Earnings per Basic Share | -0.87 | ||
| Earnings per Basic Share (USD) | -0.87 | ||
| Earnings per Diluted Share | -0.87 | ||
| Earning Before Interest & Taxes (EBIT) | -60.60M | ||
| Earning Before Interest & Taxes (USD) | -60.60M | ||
| Weighted Average Shares | 69.68M | ||
| Weighted Average Shares Diluted | 69.68M | ||
| Balance Sheet | |||
| Cash and Equivalents | 559.47M | ||
| Cash and Equivalents (USD) | 559.47M | ||
| Trade and Non-Trade Receivables | 40.92M | ||
| Current Assets | 619.14M | ||
| Property, Plant & Equipment Net | 20.27M | ||
| Total Assets | 652.40M | ||
| Total Debt | 13.87M | ||
| Current Liabilities | 48.89M | ||
| Debt Non-Current | 13.87M | ||
| Total Liabilities | 98.08M | ||
| Accumulated Retained Earnings (Deficit) | -960.58M | ||
| Accumulated Other Comprehensive Income | -5.28M | ||
| Shareholders Equity | 554.32M | ||
| Shareholders Equity (USD) | 554.32M | ||
| Assets Non-Current | 33.26M | ||
| Total Debt (USD) | 13.87M | ||
| Deferred Revenue | 37.14M | ||
| Liabilities Non-Current | 49.19M | ||
| Trade and Non-Trade Payables | 5.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.13M | ||
| Net Cash Flow from Financing | -54.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -68.64M | ||
| Capital Expenditure | -713.00K | ||
| Issuance (Purchase) of Equity Shares | 12.00K | ||
| Issuance (Repayment) of Debt Securities | -66.00K | ||
| Net Cash Flow from Investing | -713.00K | ||
| Net Cash Flow from Operations | -65.92M | ||
| Effect of Exchange Rate Changes on Cash | -1.94M | ||
| Share Based Compensation | 6.93M | ||